Sep 24, 2012
By:
Amy Ritter, PhD
ISPE has published a new guidance titled ISPE Good Practice Guide: Quality Laboratory Facilities, which defines design guidelines for quality laboratories.
|
Howard Levine of BioProcess Technology Consultants talks about what industry needs to know to enter the biosimilars game in the US.
Sep 1, 2012
By:
Amy Ritter, PhD, Nora Barry
Howard Levine of BioProcess Technology Consultants talks about what industry needs to know to enter the biosimilars game in the US.
|
NIH has awarded ten laboratories two-year grants to develop tissue chip technology, with part of the funding coming from the recently established National Center for Advancing Translational Science.
Sep 1, 2012
By:
Amy Ritter, PhD
NIH has awarded ten laboratories two-year grants to develop tissue chip technology, with part of the funding coming from the recently established National Center for Advancing Translational Science.
|
Aug 27, 2012
By:
Amy Ritter, PhD
Pfizer and Mylan have agreed to establish an exclusive long-term collaboration to develop, manufacture, distribute, and market generic drugs in Japan. The products included in the collaboration are expected to be sold under the Pfizer brand with joint labeling.
|
Aug 20, 2012
By:
Amy Ritter, PhD
South Carolina-based Altec Medical pleaded guilty to one count of conspiring to defraud FDA and to commit federal offenses in connection with a drug-diversion scheme that lasted from 2007 to 2009.
|
Aug 13, 2012
By:
Amy Ritter, PhD
Elan Corporation announced plans to spin off its discovery unit and Neotope Biosciences division to create an independent entity focused on R&D.
|
Aug 6, 2012
By:
Amy Ritter, PhD
Gilead Sciences announced that it is entering into agreements with Indian generic drug manufacturers to enhance access in developing countries to its anti-HIV medicine, emtricitabine.
|
A team from Northwestern University has demonstrated the feasibility of topical delivery of small interfering RNA (siRNA).
Aug 1, 2012
By:
Amy Ritter, PhD
A team from Northwestern University has demonstrated the feasibility of topical delivery of small interfering RNA (siRNA).
|
Jul 30, 2012
By:
Amy Ritter, PhD
First start-up funded by Merck Serono's Entrepreneur Partnership Program announced.
|
|
